sarcosine has been researched along with Diabetes Mellitus, Adult-Onset in 8 studies
cocobetaine: N-alkyl-betaine; cause of shampoo dermatitis
| Excerpt | Relevance | Reference |
|---|---|---|
| "Betaine is highly individual in overweight people with diabetes." | 9.20 | Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period. ( Chambers, ST; Elmslie, JL; Florkowski, CM; George, PM; Krebs, JD; Lever, M; Lunt, H; McEntyre, CJ; Slow, S, 2015) |
| "To quantify the association between serum sarcosine and diabetic retinopathy (DR) using weighted gene co-expression network analysis (WGCNA)." | 8.31 | Impact of sarcosine on diabetic retinopathy: Findings based on weighted gene co-expression network analysis and machine learning techniques. ( Che, M; Chen, Y; Guo, C; Jiang, D; Mao, G; Wang, H; Wang, Y; Wang, Z; Xia, Z; Zhang, X; Zhang, Z; Zheng, C, 2023) |
| "Betaine is highly individual in overweight people with diabetes." | 5.20 | Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period. ( Chambers, ST; Elmslie, JL; Florkowski, CM; George, PM; Krebs, JD; Lever, M; Lunt, H; McEntyre, CJ; Slow, S, 2015) |
| "To quantify the association between serum sarcosine and diabetic retinopathy (DR) using weighted gene co-expression network analysis (WGCNA)." | 4.31 | Impact of sarcosine on diabetic retinopathy: Findings based on weighted gene co-expression network analysis and machine learning techniques. ( Che, M; Chen, Y; Guo, C; Jiang, D; Mao, G; Wang, H; Wang, Y; Wang, Z; Xia, Z; Zhang, X; Zhang, Z; Zheng, C, 2023) |
| "Betaine deficiency is a probable cardiovascular risk factor and a cause of elevated homocysteine." | 2.79 | Extreme urinary betaine losses in type 2 diabetes combined with bezafibrate treatment are associated with losses of dimethylglycine and choline but not with increased losses of other osmolytes. ( Chambers, ST; Elmslie, JL; George, PM; Krebs, JD; Lever, M; Lunt, H; McEntyre, CJ; Parry-Strong, A; Slow, S, 2014) |
| "Patients with type 2 diabetes (n = 34) and control subjects (n = 17) were recruited." | 1.38 | Variability of plasma and urine betaine in diabetes mellitus and its relationship to methionine load test responses: an observational study. ( Chambers, ST; Dellow, WJ; George, PM; Lever, M; McGregor, DO; Slow, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anwardeen, NR | 1 |
| Cyprian, FS | 1 |
| Yassine, HM | 1 |
| Al-Thani, AA | 1 |
| Abdallah, AM | 1 |
| Emara, MM | 1 |
| Elrayess, MA | 1 |
| Che, M | 1 |
| Xia, Z | 1 |
| Jiang, D | 1 |
| Wang, Y | 1 |
| Wang, H | 1 |
| Chen, Y | 2 |
| Wang, Z | 1 |
| Zhang, X | 2 |
| Zhang, Z | 1 |
| Guo, C | 1 |
| Zheng, C | 1 |
| Mao, G | 1 |
| McEntyre, CJ | 2 |
| Lever, M | 3 |
| Chambers, ST | 3 |
| George, PM | 3 |
| Slow, S | 3 |
| Elmslie, JL | 2 |
| Florkowski, CM | 1 |
| Lunt, H | 2 |
| Krebs, JD | 2 |
| Parry-Strong, A | 1 |
| Magnusson, M | 1 |
| Wang, TJ | 1 |
| Clish, C | 1 |
| Engström, G | 1 |
| Nilsson, P | 1 |
| Gerszten, RE | 1 |
| Melander, O | 1 |
| Stechemesser, L | 1 |
| Eder, SK | 1 |
| Wagner, A | 1 |
| Patsch, W | 1 |
| Feldman, A | 1 |
| Strasser, M | 1 |
| Auer, S | 1 |
| Niederseer, D | 1 |
| Huber-Schönauer, U | 1 |
| Paulweber, B | 1 |
| Zandanell, S | 1 |
| Ruhaltinger, S | 1 |
| Weghuber, D | 1 |
| Haschke-Becher, E | 1 |
| Grabmer, C | 1 |
| Rohde, E | 1 |
| Datz, C | 1 |
| Felder, TK | 1 |
| Aigner, E | 1 |
| McGregor, DO | 1 |
| Dellow, WJ | 1 |
| Moazzami, AA | 1 |
| Bondia-Pons, I | 1 |
| Hanhineva, K | 1 |
| Juntunen, K | 1 |
| Antl, N | 1 |
| Poutanen, K | 1 |
| Mykkänen, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Flavanol-rich Dark Chocolate Consumption on Metabolic Profiles Among Obese[NCT04347304] | 74 participants (Anticipated) | Interventional | 2022-03-23 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for sarcosine and Diabetes Mellitus, Adult-Onset
5 other studies available for sarcosine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
The retrospective study of the metabolic patterns of BCG-vaccination in type-2 diabetic individuals in COVID-19 infection.
Topics: BCG Vaccine; COVID-19; COVID-19 Vaccines; Diabetes Mellitus, Type 2; Humans; Pilot Projects; Retrosp | 2023 |
Impact of sarcosine on diabetic retinopathy: Findings based on weighted gene co-expression network analysis and machine learning techniques.
Topics: Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glycated Hemoglobin; Humans; Risk Factors; Sarcosin | 2023 |
Dimethylglycine Deficiency and the Development of Diabetes.
Topics: Aged; Alleles; Diabetes Mellitus, Type 2; Dimethylglycine Dehydrogenase; Female; Genome-Wide Associa | 2015 |
Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism.
Topics: Adult; Blood Glucose; Citrulline; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Ferrit | 2017 |
Variability of plasma and urine betaine in diabetes mellitus and its relationship to methionine load test responses: an observational study.
Topics: Aged; Betaine; Biomarkers; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Female; G | 2012 |